AbbVie’s Natrelle awarded supplier agreement from Vizient
This agreement grants Vizient clients enhanced access to Natrelle, the broadest selection of breast implant options on the market
This agreement grants Vizient clients enhanced access to Natrelle, the broadest selection of breast implant options on the market
This milestone marks the first-ever NDA submission to the U.S. FDA for a drug, fully discovered and developed by an Indian pharmaceutical company
If approved, tavapadon will enhance AbbVie's leadership in Parkinson's disease by providing patients with a once daily oral treatment option
CRISPR-based detection enables highly specific molecular recognition
Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure
Replicate will receive research funding and could potentially receive up to approximately US$550 million
The safety profile in alopecia areata was generally consistent with that in approved indications, and no new safety signals were identified in this study
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
Caplin Point Laboratories has reported total income of Rs. 533.36 crores during the period ended June 30, 2025
Subscribe To Our Newsletter & Stay Updated